N. Yende

Choice architecture-based prescribing tool for TB preventive therapy: a pilot study in South Africa.

C. Hoffmann, J. Golub, E. Variava, 2020, Public health action.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial

S. A. Abdool Karim, J. Frohlich, A. Grobler, 2011, Trials.

Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial.

S. Karim, A. Kharsany, K. Mlisana, 2011, Contemporary clinical trials.

Neurodevelopmental outcomes of HIV/antiretroviral drug perinatally exposed uninfected children aged 3–6 years

M. Fowler, T. Chipato, L. Stranix-Chibanda, 2022, AIDS.

Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study.

L. Bekker, N. Garrett, I. Sanne, 2021, medRxiv.

Integrin alpha(4)beta(7) expression on peripheral blood CD4(+) T cells predicts HIV acquisition and disease progression outcomes

R. Kaul, A. Fauci, J. Ananworanich, 2022 .

CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles

B. Walker, T. Ndung’u, J. Prado, 2016, Journal of Virology.

Contraceptive Choices, Pregnancy Rates, and Outcomes in a Microbicide Trial

S. Karim, C. Baxter, S. Sibeko, 2011, Obstetrics and gynecology.